Monday, February 13, 2012
Just Diagnosed with Cancer? Chat with Experts

All SharePosts Relating To "her2"

Expert_badge PJ Hamel

PJ Hamel

(Profile)
Author, breast cancer survivor

Understanding Your Pathology Report’s Key Numbers

So, you’ve just received a copy of your pathology report from the oncologist, and you’re totally mystified by the “medicalese” it contains. Where to turn?If you’re up for studying and interpreting the entire report, check out our Guide to Understanding Your Pathology Report.But if you want a quick, “down and... Read moreChevron
posted 02/01/2011, comments (0)|
Expert_badge PJ Hamel

PJ Hamel

(Profile)
Author, breast cancer survivor

New Treatment for HER2+ Survivors

For certain women with metastatic HER2+ breast cancer, life just got a little bit brighter – literally. On January 29, the FDA granted approval to a new combination drug therapy – Tykerb (lapatinib), and Femara (letrozole) – for post-menopausal women with estrogen-receptive, HER2-positive (HER2+) metastatic breast... Read moreChevron
Expert_badge Kevin Knopf, MD

Kevin Knopf, MD

(Profile)
Medical Oncologist

The Advantages and Disadvantages of Adjuvant Chemotherapy for Breast Cancer

Data presented at the San Antonio Breast Cancer Symposium show that basically all women with HER2+ breast cancers benefit from adjuvant chemotherapy/Herceptin due to their worse prognosis. In my mind, however, there is no more controversial area in breast cancer than in which patients truly benefit from receiving adjuvant chemotherapy, among women... Read moreChevron
Expert_badge Kevin Knopf, MD

Kevin Knopf, MD

(Profile)
Medical Oncologist

Chromosome 17 and Chemotherapy

After much debate at breast tumor boards throughout the world on the importance of HER2 and topoisomerase II (an enzyme involved in DNA replication) in predicting response to Anthracyclines, it seems that an extra copy of chromosome 17 in the cancer may be predictive. Things change pretty quickly.   We typically don't analyze chromosome 17... Read moreChevron
posted 03/10/2009, comments (0)|
Expert_badge Kevin Knopf, MD

Kevin Knopf, MD

(Profile)
Medical Oncologist

All HER2 Positive Breast Cancers Should Get Adjuvant Chemotherapy and Herceptin

From the San Antonio Breast Conference in December, new data shows a higher than predicted rate of breast cancer recurrence even with very small breast cancers that are HER2 positive. The data is from the first large study to analyze early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller. All these women would... Read moreChevron
posted 02/09/2009, comments (0)|

Ask a Question

Get answers from our experts and community members.

Btn_ask_question_med
View all questions (6482) >